Estudio de seguimiento, abierto, de evaluación de investigación del tratamiento sostenido con aficamten (CK-3773274) en la miocardiopatía hipertrófica (MCH)

Aficamten (5 - 20 mg)

Aficamten tablets administered orally. During titration phase, clinic visits will occur approximately every 2-6 weeks. In the maintenance phase clinic visits will occur every 24 weeks, with safety check-in occurring every 12 weeks between visits by phone or, if desirable, in the clinic.